Pharmacokinetic Study of Perampanel in Chinese Healthy Subjects
NCT03424564 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 44
Last updated 2018-08-28
Summary
This study will be conducted to evaluate the pharmacokinetics of perampanel following single and multiple oral doses in Chinese healthy male and female participants.
Conditions
- Healthy Subjects
Interventions
- DRUG
-
Perampanel
Oral Tablet
Sponsors & Collaborators
-
Eisai Co., Ltd.
lead INDUSTRY
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-03-20
- Primary Completion
- 2018-05-25
- Completion
- 2018-05-25
Countries
- China
Study Locations
More Related Trials
-
A Comparative Pharmacokinetic Study of Single-Dose Administration of HR091506 Tablets From Different Batches in Healthy Subjects
NCT07076459 ·Status: COMPLETED ·Phase: PHASE1
-
The Pharmacokinetics of D565 and the Drug Effect of D565 on Pharmacokinetic Characteristics of D930
NCT03034486 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Pharmacokinetics/Pharmacodynamics of SHR3824 in Patients With Hepatic Impairment
NCT03160014 ·Status: UNKNOWN ·Phase: PHASE1
-
A Pharmacokinetic Study of Modified Release (MR) Formulations of MIN-101 in Healthy Subjects
NCT03038646 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetic Study of Daptomycin in Healthy Chinese Subjects Living in China
NCT00858325 ·Status: COMPLETED ·Phase: PHASE1
-
A Pharmacokinetic Study of Intravenous NTM-001 in Healthy Chinese Subjects
NCT05382546 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics (Drug Levels in Blood) of BMS-986165 When Taken as Various Solid Tablet Prototypes by Healthy Participants
NCT04249284 ·Status: COMPLETED ·Phase: PHASE1
-
Mass Balance Study of [14C]HSK31858 in Healthy Adult Male Chinese Subjects.
NCT06569784 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Implant Pharmacokinetic and Pharmacodynamic Study
NCT03634137 ·Status: COMPLETED ·Phase: PHASE1
-
A Pharmacokinetic Study of TQB3101 in Chinese Healthy Subjects
NCT04804904 ·Status: COMPLETED ·Phase: PHASE1
-
HI Study to Assess and Compare the Pharmacokinetic Parameters of MD1003 in Hepatic Impaired Patients and Healthy Subjects
NCT04252417 ·Status: TERMINATED ·Phase: PHASE1
-
Study of HS-10384 in Participants of Chinese Postmenopausal Women
NCT06122181 ·Status: RECRUITING ·Phase: PHASE1
-
A Study to Compare Pharmacokinetic and Safety Profiles of Different Formulations of SHR-1314 After Subcutaneous Injection in Healthy Subjects
NCT04326881 ·Status: UNKNOWN ·Phase: PHASE1
-
Pharmacokinetics, Mass Balance, and Metabolism of [14C]HSK31679 in Healthy Adult Male Volunteers.
NCT06258746 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
A Pharmacokinetics (PK) and Safety Study of Oral Fampridine-PR 10 mg in Chinese, Japanese, and Caucasian Adult Healthy Volunteers
NCT01215084 ·Status: COMPLETED ·Phase: PHASE1
-
A Study To Characterize Mass Balance Of [14C] HDM1002 in Chinese Healthy Subjects
NCT06576401 ·Status: RECRUITING ·Phase: PHASE1
-
A Study to Evaluate the Drug Levels of BMS-986165 When Taken as Various Solid Tablet Prototypes by Healthy Participants
NCT04536961 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of The Excretion Balance, Pharmacokinetics and Metabolism of A Single Oral Dose of [14C]-Labeled RO4917523 in Healthy Male Volunteers
NCT01592890 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Mass Babance and Biotransformation of [14C]SHR6390 in Healthy Adult Male Volunteers
NCT04616742 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Pharmacokinetics, Metabolism, and Excretion of AK0529
NCT03400995 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Pharmacokinetics/Pharmacodynamics of HSK3486 in Patients With Hepatic Impairment
NCT04145596 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess Pharmacokinetics, Safety, and Tolerability of MT-7117 in Subjects With Normal and Impaired Hepatic Function
NCT04116476 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess Mass Balance, Pharmacokinetics, Metabolism, and Excretion of Emraclidine in Healthy Adult Male Participants
NCT06301971 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics, Mass Balance, and Metabolism of [14C]HSK21542 in Healthy Adult Male Volunteers.
NCT05835934 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics Study of MCI-186 in Subjects With Mild or Moderate Hepatic Impairment
NCT03289234 ·Status: COMPLETED ·Phase: PHASE1